PAX5-AUTS2 fusion resulting from t(7;9)(q11.2;p13.2) can now be classified as recurrent in B cell acute lymphoblastic leukemia.
Coyaud
E
E
Struski
S
S
Dastugue
N
N
Brousset
P
P
Broccardo
C
C
Bradtke
J
J
D014408:Biomarkers, Tumor / Q000097:blood / Q000235:genetics*; D001772:Blood Cell Count; D002675:Child, Preschool; D002897:Chromosomes, Human, Pair 7 / Q000235:genetics*; D002899:Chromosomes, Human, Pair 9 / Q000235:genetics*; D003598:Cytoskeletal Proteins; D005260:Female; D006801:Humans; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D051757:PAX5 Transcription Factor / Q000235:genetics*; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000145:classification* / Q000235:genetics* / Q000628:therapy; D011506:Proteins / Q000235:genetics*; D014157:Transcription Factors; D014178:Translocation, Genetic / Q000235:genetics*
C554283:AUTS2 protein, human; D014408:Biomarkers, Tumor; D003598:Cytoskeletal Proteins; D015514:Oncogene Proteins, Fusion; D051757:PAX5 Transcription Factor; C497281:PAX5 protein, human; C554284:PAX5-AUTS2 fusion protein, human; D011506:Proteins; D014157:Transcription Factors